. Before using capillaries were conditioned with 1 M NaOH solution for 30 min, followed by deionized water during 20 min and a finally with the electrolyte buffer for 30 min. At the beginning of every working day the capillary was flushed with 1 M NaOH for 15 min, followed by deionized water for 10 min and then by electrolyte buffer for 15 min. Between each run, the capillary was rinsed with 1 M NaOH for 2 min, deionized water for 1 min and buffer solution for 2 min. Furosemide was used as internal standard. All assays were done in triplicate. To calculate the drug content in the nanoparticles, linear standard curves were constructed. The MEKC method was validated with respect to linearity, precision repeatability and the limits of quantification and detection. In this research, the MEKC method was developed and validated for the quantitative determination of diclofenac sodium and dexamethasone in the resulting PLGA nanoparticles using furosemide as internal standard ( Figure S2 ). The MEKC method was validated according to the International Conference on Harmonization (ICH) guideline. Linear analytical curves were obtained in the concentration ranges of 75.0 -225.0 µg mL -1 and 100.0 -300.0 µg mL -1 , for diclofenac sodium and dexamethasone, respectively. The determination coefficient (R 2 ) was better than 0.99.
The detection and quantification limits were 0.18 µg mL -1 and 0.55 µg mL -1 ; and 0.19 µg mL -1 and 0.56 µg mL -1 for DS and DX, respectively. The precision expressed as percentage of relative standard deviation (RSD) was less than 2.0%. Figure S2 . Electropherograms of (a) non-drug loaded nanoparticle, (b) loaded nanoparticle and (c) standard drugs (sodium diclofenac 100.0 µg mL -1 , dexamethasone 100.0 µg mL -1 and furosemide 100.0 µg mL -1 ). An important factor, which has influence on the nanoparticle´s size, is the combination of the concentration values of PLGA and Pluronic. When the amount of PLGA is constant, the size of nanoparticles changes with the amount of surfactant. If the Pluronic concentration increases, the hydrodynamic diameter average of the nanoparticles decreases ( Figure S3 ). Data showed that for any combination of values of PLGA concentration and sonication time, the size of the nanoparticles consistently decreased as the concentration of Pluronic increased. It has been reported that at high concentrations, more surfactant can be oriented to the organic/aqueous interface leading to an efficient reduction of the interfacial tension, resulting in a significant increase in the shear stress during emulsification. Consequently, there is a formation of smaller emulsion droplets. Figure S5 . Effect of Pluronic concentration (3% and 5%) on particle size.
3-Optimization of DX-DS/PLGA NPs
1%PLGA,25s 2%PLGA,25s 1%PLGA,45s 3% 5%
During the preparation of nanoparticles, the emulsification process critically influences the nanoparticle size. In this case, two different sonication times, 25 and 45 seconds, were tested under different concentrations of PLGA and Pluronic ( Figure S4 ). As it could be expected, the increase in the sonication time caused a reduction in the hydrodynamic diameter in all the studied formulations. Figure S6 . Effect of sonication time (45s and 25s) on particle size
An increase in the amount of PLGA ( Figure S5 ) causes an increase in the percentage of encapsulation efficiency (%EE) of drugs for the NPs formulations. This effect can be explained by the fact that an increase in the amount of PLGA in the organic phase causes variation in the viscosity and surface tension of the organic phase, which consequently, affects the emulsification process Figure S7 . Effect of PLGA amount (mg) on the encapsulation efficiency (%EE) of dexamethasone (DX) and diclofenac sodium (DS). Pluronic concentration %w/v and sonication time were maintained constant.
1%PLGA, 2%PLGA, 1%PLGA, 2%PLGA, 3%Pluronic 3%Pluronic 5%Pluronic 5%Pluronic 25 s 45 s 25s/3% 45s/3% 25s/5% 25s/3% 45s/3% 25s/5% 45s/5% 6-Sem Figure S8 . SEM images and particle size distributions for PLGA nanoparticles loaded with DS+DX. (In the Table 2 conditions of elaboration).
